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Background
Heart failure (HF) is the end stage of cardiovascular disease [1], including coronary heart 
disease, rheumatic heart, and high blood pressure [2–4]. However clinical studies have 
found that the breathing pattern of HF is distinguishing with the normal person [5].
Abstract 
Background: PM2.5 is an important factor to affect the patients with respiratory and 
cardiovascular diseases. Clinical studies have found that the morbidity and mortality 
of patients with heart failure (HF) have a close relationship with the movement and 
deposition state of PM2.5. One reason is that the breathing pattern of patients with 
HF has obvious difference with healthy people, however the effect caused by these 
differences on the distribution regularity of PM2.5 in the respiratory tract is still unclear. 
Hence, a computational fluid dynamics simulation was conducted to clarify the aero-
dynamic effect of breathing pattern of patients with HF on respiratory system.
Methods: Ideal upper respiratory tract geometric model was established based on 
standardized aerosol research laboratory of Alberta and Weibel A dimension. The 
discrete phase method is used to calculate the movement of the airflow and particles. 
The flow rate were chosen as the inlet boundary conditions, and the outlets are set at 
a constant pressure. The rate of particle deposition, distribution location, wall pressure, 
flow velocity and wall shear stress are obtained, and compared to the normal control.
Results: The results demonstrated that the rate of escaped particles in every bron-
chial outlet of the patients with HF was more than the normal controls, meanwhile the 
trapped was less (1024 < 1160). There was higher by 12.9% possibility that the PM2.5 
entered the lungs than the normal control.
Conclusion: The aerodynamic performances of HF patients are different from normal 
control. Compared to the normal control, under similar environment, there is higher 
possibility of PM2.5 moving into lungs, and these particles could affect the function 
of the respiratory system, resulting in the deterioration of the state of cardiovascular 
system. In short, it’s necessary to pay more attention to the living environment of HF 
patients, to reduce the content of PM2.5 particles in the air, and reduce the damage of 
PM2.5 particles caused by breathing patterns.
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Meanwhile, with the increase of awareness of air pollution, PM2.5 particles on the 
impact of cardiovascular patients have also received more and more attention. PM2.5 
refers to the micron particles whose equivalent diameter is less than or equal to 2.5 µm, 
accounting for more than 74% of the total air pollution particles. Because of the large 
particles surface area, small particle diameter, and containing a large amount of harm-
ful toxic characteristics, PM2.5 can follow breathing into the human body, and even 
reach the alveoli and in the blood [6–9]. So the damage of PM2.5 to the lung is obvious 
and direct, moreover its effects on the heart become more and more important for the 
researchers in recent years. Epidemiological investigation showed that PM2.5 is asso-
ciated with morbidity and mortality of heart failure. The concentration of PM2.5 rises 
3 µg/m3, the number of heart failure patients increases by 4.70% [10–14]. Thus, PM2.5 
pollution and the morbidity and mortality of heart failure has certain relevance. But its 
mechanism is still not clear.
Experimental results show that the influence of atmospheric pollutants on the heart 
failure, on the one hand is because of some components of PM2.5 directly into the cir-
culatory system induced the formation of blood clots, and impact on the cardiovascu-
lar system [6, 15]; on the other hand, PM2.5 can produce inflammation and stimulate 
respiratory tract release cytokines, cause blood vessel damage, leading to thrombosis, 
influence the stability of atherosclerotic plaques [7–9]. British and Indian joint research 
shows that air pollution is closely related to the hospitalization rate and mortality rate of 
heart failure. The researchers selected 35 relevant researches to study the correlation of 
pollution particle concentration and hospitalization or death rate. PM2.5 concentrations 
increase 10 µg/m3, rate of hospitalization and mortality increased by 2.12%.
Pope C A assessed the relationship between air pollution and the admission and 
mortality rate of decompensated heart failure, based on a systematic review and meta-
analysis of the previous research. Results show that the air pollution and heart failure 
hospitalization rate and mortality has a close correlation [6]. Meanwhile, it has a strong 
correlation between the time length of exposure to air pollution and the risk of hospitali-
zation and death caused by heart failure. The longer the exposure time is, the greater the 
impact of the continuing role of PM2.5.
Research shows that the movement and deposition of the air pollution particles in the 
upper respiratory tract are closely linked to the respiratory rate, vital capacity param-
eters [18, 19]. The computational fluid dynamic (CFD) as an effective method were 
widely used to evaluate the aerodynamic effects of several diameters of particles on 
respiratory tract. Benjamin [16] found that under different constant speed respiratory 
rate, the movement and deposition of particles in the upper respiratory tract have obvi-
ous difference. Clement [17] studies have found that under the same respiratory rate, 
the movement and deposition of different particle diameter are also different. Zhang 
[18–24] had calculated the movement and deposition of PM2.5 particles in the upper 
respiratory tract when the normal human respiratory rate is constant (15–60 l/min) by 
using the method of fluid dynamics of discrete phase. The calculation results show that 
the particle deposition rate and respiratory flow rate and particle diameter are corre-
lated, the deposition rate is higher in the throat and tracheal bronchus bifurcation, and 
with the increase of respiration velocity, particle deposition rate will decline in the upper 
respiratory tract, so the possibility of getting into the lungs will be higher. Cheng [25] 
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researched the effects of particle size and respiratory rate on the deposition results in 
human oral respiratory tract by comparing with nine different diameter of particles and 
the conditions of three kinds of respiratory rate. The result implied that the smaller par-
ticle’ diameter and the higher respiratory rate will cause the lower deposition rate and 
the higher escaped rate. Vasconcelos [27] calculated the particle escape rate and capture 
rate in the tertiary bronchi branch by using the method of computational fluid dynam-
ics. Li [24, 26] adopted the approach of multiphase flow, and sets the particles to the 
discrete phase, air to continuous phase. So he made use of the real human bronchial 
model to calculate the movement of micron particles, and got the results of the particle 
deposition position. Furthermore, he put forward that the real breathing entry condi-
tions could be set as the further work optimization.
As we can see from the above several studies, CFD has been used to model airflow, tem-
perature and particle deposition within the human upper respiratory tract [15–25]. In 
these studies, researchers adopted constant flow to simulate the fluid dynamics movement 
of particles in the respiratory system, however gas flow rate, the frequency of breathing, 
tidal volume, inspiratory time accounts for the proportion of the respiratory cycle index 
did not study. Different breathing rate and tidal volume will significantly change the fluid 
dynamics inside the upper respiratory tract environment, may affect the movement of 
PM2.5. But the upper respiratory tract in patients with heart failure in the influence of the 
particle movement law is not clear. So the movement of PM2.5 particles in patients with 
heart failure of the upper respiratory tract and deposition state is necessary.
In order to clarify this problem, numerical studies were conducted. Ideal upper res-
piratory tract models with three levels bronchi were established based on physiological 
data. The breathing flow rate, derived from previous work, were chosen as the bound-
ary conditions. The flow pattern in the respiratory tract, the trapped rate ratios of parti-
cles, the position of particles deposition, flow interface, and wall shear stress (WSS) were 
used as the factors to evaluate the hemodynamic states.
Methods
Geometric model
The upper respiratory tract ideal model was constructed by using a commercial soft-
ware SolidWorks14.0 (Solidworks Corp., MA, USA), referred to the standardized ARLA 
[28] and Weibel A [29] model dimension (Table 1). The size is measured by screening of 
three volunteers without a history of acute and chronic upper respiratory tract disease.
These structures are integrated according to the dimension, so it can obtain the four-
generation human airway model (Fig. 1) that has been widely applied [18–24]. Figure 1a, 
b is the model of parts before trachea and bronchus, respectively. The model consist of 
the soft palate, the uvula, the epiglottis, the trachea and three level bronchus, and it can 
assume that the upper respiratory tract structure of heart failure patients had no obvious 
change.
CFD simulation and boundary conditions
Transport equations
The air flow of upper respiratory tract calculation is based on three-dimensional incom-
pressible Navier-Stokes equation (1) and (2):
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Table 1 Statistics of key dimensions of the upper respiratory tract
Key parts ARLA model and Weibel A model Angle (°)
Diameter (mm) Length (mm)
Soft palate 27*15 24.1 –
Uvula 22.7*14 6.8 –
Epiglottis 31.2*15 39.8 –
Trachea 14.3 267.4 0
Left main bronchus 8.7 50.6 25
Right main bronchus 13.1 22.2 50
Left secondary bronchus 9 12.9 37
Right secondary bronchus 8.9 16.3 37
Left third bronchus 6 9.3 37
Right third bronchus 6.4 11 37
Fig. 1 The ideal human upper respiratory tract model. VT tidal volume, VE minute ventilation, T1 inspiratory 
time, Ttot total respiratory time, VT/T1 mean inspiratory flow, bpm breaths per minute. a The lateral view of 
the parts abive trachea. b The front view of the bronchi
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where ρ stands for the density of air, V  is the fluid velocity vector, p is the pressure, µ is 
the dynamic viscosity.
The orbit of discrete phase particles is solved by particles force differential equation 
of integral Laplace coordinates. The force equilibrium equation of particles in Cartesian 
coordinates (x direction) is:
where FD(v − vp) stands for unit mass drag of particles, gx is the gravity in x direction, Fx is 
the other forces acting on the particles. For a diameter of 1–10 microns, FD is defined as:
where v is the fluid velocity, vp is the particle velocity, µ is the dynamic viscosity, ρ is the 
fluid density, ρp is the particle density, dp is the particle diameter.
Drag coefficient is Cunningham correction of Stokes’ drag force formula, the calcula-
tion formula is:
where λ is the mean free path of gas molecules.
The particle diameter set in the calculation (1–2.5 µm) match the conditions of Eq. 5 
(1–10  µm), so the Saffman lift need to be considered in the calculation. The general 
expression of the lift is:
where dij is the fluid deformation rate tensor.
The escaped rate and particle deposition rate is an important index to show the move-
ment state of the particles, and the escaped rate is defined as
where {N1,N2, . . . ,N8} is the number of particles that escaped from every bronchi out-
let, N0 is the number of particles that injected from the inlet surface.
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where N is the number of particles released from the entry of the respiratory ideal 
model, mp is the mass flow rate of particle flow, Aface is the surface area of the particle 
collision boundary. So the adsorption of particles on the wall can be shown by deposi-
tion contour.
Boundary conditions
Ambtosino [4] tested the ventilator pattern of 45 patients with chronic heart failure and 
22 normal through the experimental measurement, and got the statistics of the mean 
and SD (standard deviation) of tidal volume (VT), respiratory frequency and inspiratory 
time (T1). There was some difference of the results, as showed in Table 2.
Human unsteady breath flow-time curve can be measured by using NR—6 nasal sound 
reflection instrument. According to the index of VT and T1 in Table 2, the Fourier trans-
form was carried out on the flow-time curve to change the timeline and amplitude. So 
the flow-time curve of normal and NYHA III heart failure patients can be got, as shown 
as Fig. 2. The bronchi outlets are set at a constant pressure of 1.0 atm.
Numerical methods
The modelled upper respiratory tract ideal model was read into the CFD solver, ANSYS 
Fluent 14.5(ANSYS Inc., PA, USA). And tetrahedron elements are used during the 
meshing process. The base size of the mesh is 0.2 mm but the final size is determined 
through mesh-independent evaluation with a tolerance of <0.3%. Depending on the size 
Table 2 Ventilatory pattern of HF and controls
Mean (SD); NYHA New York heart association, VT tidal volume, VE minute ventilation, T1 inspiratory time, Ttot total respiratory 
time, VT/T1 mean inspiratory flow, bpm breaths per minute
Controls HF (NYHA III)
VT, ml 920 (155) 949 (297)
Respiratory frequency, bpm 16 (4) 18 (5)
VE, l/min 14.9 (4.1) 16.6 (5.5)
T1/Ttot, % 43 (5) 44 (4)
VT/T1, ml/s
−1 568 (147) 622 (205)
Fig. 2 The flow-time curve of normal and heart failure patients. The eight marked points (t1, t2, t3, t4, and t1′, 
t2′, t3′, t4′) on the two curve are four representative times respectively
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of the model, 1017,289 elements are included. Further the grid independence test is con-
ducted to determine the optimal grid numbers for the computation. The test result was 
shown as Table  3. According to the results, 1.01 million elements are enough for this 
study. The mesh is shown as Fig. 3.
The flow-time boundary conditions are imported in the Fluent 14.5. All solid bounda-
ries on the airway surfaces were specified as rigid, no-slip walls. And it was assumed that 
all particles can be trapped by the wall. Correspondingly the inlet velocity reaches value 
as high as the low-Reynolds-number (LRN) standard k−ω turbulence model was applied 
to the domain with a turbulence intensity of 5% specified for all flow boundaries and for 
initialization. The turbulence model has previously been used in respiratory flow simula-
tions [16–27].
The total flow through the model consisted of two components, standard air and car-
bon (C) particles, the highest percentage of the composition caused by air pollution. 
The air was modelled as an ideal gas with a dynamic viscosity of 1.7894 × 10−5 kg/(m s) 
and density of 1.225  kg/m3, while C particle was modelled with a constant density of 
Table 3 The grid independence test
RT the rate of trapped particles
Nodes Elements RT (%) Relative error (%)
107270 545774 78.4 4.21
194088 1017289 81.7 1.22
336768 1768311 82.7
Fig. 3 The mesh result of the ideal human upper respiratory tract model
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2000 kg/m3 and diameters of 0.8, 1.2, 2.5 µm. The model was solved isothermally with 
a total condition temperature of 298.15 K as it was assumed the thermal effects on the 
flow were negligible.
Results
The deposition and escaped of PM2.5
Figure  4 was the statistics of deposition and escaped of PM2.5. For the patients with 
heart failure, there are 18.3% of PM2.5 that would move into next level bronchi, even 
reach the lungs. Compared to the normal control, RE is higher by 12.9% than the normal 
control. The statistics indicated that the number of escaped particles in every bronchial 
outlet of the patients with HF are more than the normal controls, meanwhile the trapped 
particles were less (1024 < 1160). That is, in this study, there was higher possibility that 
the PM2.5 entered the lungs via the upper respiratory tract of the patients with HF than 
the normal controls. The virus carried by particles would affect the respiratory system 
and cardiovascular system seriously. Then the PM2.5 aggravated the burden of cardio-
vascular system in the patients with HF.
Figure 5 was the contour of the location of particles deposition. The contours repre-
sent the impact degree of the particles to the airway wall and the deposition location. 
Compared with the normal controls, there are more trapped particles in larynx and tra-
chea of patients with HF (4.47 kg/m2). While the most particles had been trapped before 
the trachea. As a result of the breathing patterns of heart failure patient have the charac-
teristics of high respiratory rate, high volume, the possibility of PM2.5 into the trachea 
and bronchus is greatly increased, then harmful to respiratory system and cardiovascu-
lar system.
Wall shear stress (WSS) and wall pressure
Figure 6 was the contour of the shear stress (WSS) of the patients with HF (a) and the 
normal controls (b). Compared to the controls, the upper respiratory tract of the patients 
with HF suffer from higher WSS (3 vs 0.0005 Pa). The wall pressure are shown in Fig. 7. 
It showed that the pressure change was considerable during the whole respiratory cycle 
Fig. 4 Statistics of deposition and escaped of particles
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of HF than the controls (300 vs 10 Pa). As we can see from Fig. 8, the velocity streamline 
of patients with HF at the moment of the fastest breath in and out was showed. The air 
flow was linear in trachea and bronchus, and irregular flow in the throat, so less particles 
have been trapped by the wall. This was the main factor to effect the particles’ movement 
and deposition. So the upper respiratory system of HF could bear more pressure and 
damage. It could also induce the inflammation in upper respiratory tract.
Discussion
HF as a severe cardiovascular disease has a higher demand on the surrounding envi-
ronment, due to the particularity of body state and the seriousness of the air pollution. 
Although many studies focus on aerodynamic in upper respiratory tract [28–32], there is 
no study to link the two directions to discuss the effect of PM2.5 on the HF.
For the CFD simulation of airflow in the respiratory tract, several important assump-
tions are made, including highly simplified geometry, the rigid airways with smooth 
surface, the no-slip and absolute-adsorption boundary conditions, modeling air as an 
incompressible Newtonian fluid with constant density and viscosity [1.225  kg/m3 and 
1.7894 ×  10−5kg/(m s)], steady static pressure and the lack of refined boundary mesh 
Fig. 5 The particle deposition rate contours of patients with HF (a) and the normal (b) control
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[33–35]. The inflow flow is the accepted difference between the normal and HF patients 
[4, 36–40], and there is no study to show that there are other factors to affect the PM2.5 
movements and depositions in HF patients, so the assumption of the same upper airway 
structure is made. These assumptions have been accepted and widely used [2–10]. The 
Fig. 6 The wall shear stress (WSS) at different time of patients with HF (a) and the normal (b) control
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specified velocity (or flow rate) reported in literature was constant, including 15, 30, and 
60 l/min. In fact, in order to performance the breathing characteristics in patients with 
heart failure, the breathing velocity is individualized according to the change of the car-
diovascular system function in patients with heart failure.
Fig. 7 The wall pressure contours at different time of patients with HF (a) and the normal (b) control
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The rate of deposition and escaped is necessary to discuss the air flow state in the res-
piratory tract. For the patients with HF in this study however, the particle deposition rate 
is low, and the escape rate is high, so the particles have a much higher likelihood into the 
lungs. As we can see from Fig. 5, this is due to HF patients with inhalation of high value 
(949 > 920 ml), and the respiratory cycle is short (18 > 16 bpm), causing the high slope of 
respiratory rate, so the possibility of escape of the PM2.5 particles flow increases. In the 
present study, the inlet flow was the only variable to impact the movement of PM2.5, and 
several factors such as the structure of upper respiratory tract and particle types were 
ignored. There are no studies to show these differences, so it could be the further study.
Wall shear stress has been considered an important factor. Figures  6 and 7 show 
that the WSS was higher in the entrance and bronchus divides of patients with heart 
failure,and the wall pressure and WSS were obviously higher in HF than the normal con-
trol. So the upper respiratory system of HF could bear more pressure and damage to 
make further deterioration of the patients. Figure 8 shows that the gas flow velocity is 
very high (18 m/s) in the throat. The results were unreasonable, and this is associated 
with the narrow structure of the larynx caused by rigid boundary. So the study just pro-
vide some qualitative analysis and guidance. This also inferred that the respiratory and 
cardiovascular system have inseparable relationship. So the study can be considered as a 
bridge to research the cardiovascular diseases by the respiratory state. It also can explain 
the clinical phenomenon that with the increased concentration of PM2.5, the morbidity 
and mortality of HF patients would rise [7–9].
Limitations for the present study should be pointed out as well. Firstly, the inlet flow 
measurement were not standard, because the fact velocity curve wasn’t been recorded. 
Secondly, the CFD results are not validated by the experimental measurement. Thirdly, 
the refined boundary mesh was not be verified. Fourthly, the wall of upper respiratory 
tract was set to be absolute-adsorption, so the particles could stop if it contact with the 
wall. Fifthly, the particles’ types and quantity distribution was not statistical analyzed. 
Finally, the environment temperature and the upper respiratory tract mucous membrane 
Fig. 8 The velocity streamline of patients with HF at two different moment
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are not considered. These factors will be the next research objects of the project in com-
bination with clinical trials and cell experiment.
Conclusions
In order to clarify the movement and deposition of PM2.5 particles and the hemody-
namic difference between patients with heart failure and normal person, numerical stud-
ies were conducted. Results demonstrated that under the breathing pattern of patients 
with HF, the aerodynamic and particles movement states are distinguishing. The prob-
ability of PM2.5 entered into the lungs is higher, and the location of particle deposition 
was distributed mainly over the upper respiratory tract. The HF also has a higher WSS at 
the bifurcation of the bronchus and throat. These regions are prone to develop respira-
tory disease, further affect the cardiovascular system. These results are consistent with 
the physical experiment results of the upper respiratory tract adsorption to the particles.
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